Xeljanz 11mg (Tofacitinib Citrate Tablet) 11mg

Xeljanz 11mg (Tofacitinib Citrate) is a prescription tablet used to treat moderate to severe rheumatoid arthritis and psoriatic arthritis. This 11mg strength formulation comes in a 91-tablet pack for convenient monthly supply. Ideal for adults seeking consistent arthritis management with a trusted medication.

Strength

11mg

Pack Size

91s

Storage

Ambient

Manufacturer / TM Owner

Pfizer Pharmaceutical LLC USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xeljanz 11mg (Tofacitinib Citrate) is commonly prescribed to reduce inflammation and joint damage in adults with rheumatoid arthritis or psoriatic arthritis. It works by targeting specific pathways in the immune system to help control symptoms when other treatments have not been effective. Patients often use it to improve mobility and daily functioning.

Side Effects

Many users report reduced joint pain and stiffness within weeks of starting Xeljanz 11mg. Swelling in affected joints may decrease, making everyday activities more comfortable. Some patients notice improved energy levels as inflammation subsides, though individual responses vary.

Precautions & Warnings

Store Xeljanz 11mg at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Always check the expiration date before taking a dose. If you have questions about storage or handling, consult your pharmacist for guidance.

Avoid Interactions

Xeljanz 11mg may interact with certain medications, including strong immunosuppressants and some antifungals. Avoid grapefruit products while taking this medication, as they can affect how your body processes the drug. Always inform your healthcare provider about all prescription and over-the-counter drugs you are using.

Frequently Asked Questions

Xeljanz 11mg is used to treat moderate to severe rheumatoid arthritis and psoriatic arthritis in adults.

Store Xeljanz 11mg at room temperature in a dry place, away from direct light and moisture.

It may interact with certain drugs; consult your healthcare provider before combining medications.

Some patients notice symptom improvement within weeks, though individual results vary.

Long-term safety depends on individual health factors; discuss risks and benefits with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.